REFERENCES
- Anderson, A. R., A. M. Weaver, P. T. Cummings, and V. Quaranta. 2006. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127:905–915.
- Banziger, C., D. Soldini, C. Schutt, P. Zipperlen, G. Hausmann, and K. Basler. 2006. Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell 125:509–522.
- Barth, A. I., D. B. Stewart, and W. J. Nelson. 1999. T-cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithelial cells expressing mutant beta-catenin. Proc. Natl. Acad. Sci. USA 96:4947–4952.
- Bartscherer, K., N. Pelte, D. Ingelfinger, and M. Boutros. 2006. Secretion of Wnt ligands requires Evi, a conserved transmembrane protein. Cell 125:523–533.
- Bi, M., C. Naczki, M. Koritzinsky, D. Fels, J. Blais, N. Hu, H. Harding, I. Novoa, M. Varia, J. Raleigh, D. Scheuner, R. J. Kaufman, J. Bell, D. Ron, B. G. Wouters, and C. Koumenis. 2005. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J. 24:3470–3481.
- Brown, J. M., and A. J. Giaccia. 1998. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58:1408–1416.
- Burrus, L. W., and A. P. McMahon. 1995. Biochemical analysis of murine Wnt proteins reveals both shared and distinct properties. Exp. Cell Res. 220:363–373.
- Denko, N. C., L. A. Fontana, K. M. Hudson, P. D. Sutphin, S. Raychaudhuri, R. Altman, and A. J. Giaccia. 2003. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22:5907–5914.
- Ellgaard, L., and L. W. Ruddock. 2005. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep. 6:28–32.
- Giles, R. H., M. P. Lolkema, C. M. Snijckers, M. Belderbos, P. van der Groep, D. A. Mans, M. van Beest, M. van Noort, R. Goldschmeding, P. J. van Diest, H. Clevers, and E. E. Voest. 2006. Interplay between VHL/HIF1α and Wnt/β-catenin pathways during colorectal tumorigenesis. Oncogene 25:3065–3070.
- Giles, R. H., J. H. van Es, and H. Clevers. 2003. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653:1–24.
- Graeber, T. G., C. Osmanian, T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe, and A. J. Giaccia. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88–91.
- Haynes, C. M., E. A. Titus, and A. A. Cooper. 2004. Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol. Cell 15:767–776.
- Jiang, Y. A., L. F. Fan, C. Q. Jiang, Y. Y. Zhang, H. S. Luo, Z. J. Tang, D. Xia, and M. Wang. 2003. Expression and significance of PTEN, hypoxia-inducible factor-1 alpha in colorectal adenoma and adenocarcinoma. World J. Gastroenterol. 9:491–494.
- Kaidi, A., A. C. Williams, and C. Paraskeva. 2007. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol. 9:210–217.
- Kitajewski, J., J. O. Mason, and H. E. Varmus. 1992. Interaction of Wnt-1 proteins with the binding protein BiP. Mol. Cell. Biol. 12:784–790.
- Koong, A. C., E. A. Auger, E. Y. Chen, and A. J. Giaccia. 1994. The regulation of GRP78 and messenger RNA levels by hypoxia is modulated by protein kinase C activators and inhibitors. Radiat Res. 138:S60–S63.
- Kostova, Z., Y. C. Tsai, and A. M. Weissman. 2007. Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation. Semin. Cell Dev. Biol. 18:770–779.
- Koumenis, C., and B. G. Wouters. 2006. “Translating” tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways. Mol. Cancer Res. 4:423–436.
- Kurayoshi, M., H. Yamamoto, S. Izumi, and A. Kikuchi. 2007. Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling. Biochem. J. 402:515–523.
- Logan, C. Y., and R. Nusse. 2004. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20:781–810.
- Mason, J. O., J. Kitajewski, and H. E. Varmus. 1992. Mutational analysis of mouse Wnt-1 identifies two temperature-sensitive alleles and attributes of Wnt-1 protein essential for transformation of a mammary cell line. Mol. Biol. Cell 3:521–533.
- May, D., A. Itin, O. Gal, H. Kalinski, E. Feinstein, and E. Keshet. 2005. Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer. Oncogene 24:1011–1020.
- Mazieres, J., L. You, B. He, Z. Xu, A. Y. Lee, I. Mikami, F. McCormick, and D. M. Jablons. 2005. Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis. Oncogene 24:5396–5400.
- Mikels, A. J., and R. Nusse. 2006. Wnts as ligands: processing, secretion, and reception. Oncogene 25:7461–7468.
- Papandreou, I., R. A. Cairns, L. Fontana, A. L. Lim, and N. C. Denko. 2006. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3:187–197.
- Papandreou, I., C. Krishna, F. Kaper, D. Cai, A. J. Giaccia, and N. C. Denko. 2005. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res. 65:3171–3178.
- Pedram, M., C. N. Sprung, Q. Gao, A. W. Lo, G. E. Reynolds, and J. P. Murnane. 2006. Telomere position effect and silencing of transgenes near telomeres in the mouse. Mol. Cell. Biol. 26:1865–1878.
- Polakis, P. 2000. Wnt signaling and cancer. Genes Dev. 14:1837–1851.
- Romero-Ramirez, L., H. Cao, D. Nelson, E. Hammond, A. H. Lee, H. Yoshida, K. Mori, L. H. Glimcher, N. C. Denko, A. J. Giaccia, Q. T. Le, and A. C. Koong. 2004. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 64:5943–5947.
- Schwaller, M., B. Wilkinson, and H. F. Gilbert. 2003. Reduction-reoxidation cycles contribute to catalysis of disulfide isomerization by protein-disulfide isomerase. J. Biol. Chem. 278:7154–7159.
- Shibamoto, S., K. Higano, R. Takada, F. Ito, M. Takeichi, and S. Takada. 1998. Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells 3:659–670.
- Takada, R., Y. Satomi, T. Kurata, N. Ueno, S. Norioka, H. Kondoh, T. Takao, and S. Takada. 2006. Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev. Cell 11:791–801.
- Tu, B. P., S. C. Ho-Schleyer, K. J. Travers, and J. S. Weissman. 2000. Biochemical basis of oxidative protein folding in the endoplasmic reticulum. Science 290:1571–1574.
- Tu, B. P., and J. S. Weissman. 2002. The FAD- and O(2)-dependent reaction cycle of Ero1-mediated oxidative protein folding in the endoplasmic reticulum. Mol. Cell 10:983–994.
- Willert, K., J. D. Brown, E. Danenberg, A. W. Duncan, I. L. Weissman, T. Reya, J. R. Yates III, and R. Nusse. 2003. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423:448–452.
- Woodward, W. A., M. S. Chen, F. Behbod, M. P. Alfaro, T. A. Buchholz, and J. M. Rosen. 2007. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc. Natl. Acad. Sci. USA 104:618–623.